Right here, we experienced an incident that could be drastically resected for peritoneal dissemination twice following the colon cancer surgery.The treatment for peritoneal dissemination of hepatocellular carcinoma(HCC)remains become founded. Therefore, peritoneal recurrence ofHCC has an undesirable prognosis. Right here, we report a case ofperitoneal recurrence ofHCC after a liver resection. The in-patient underwent surgery for peritoneal recurrence 5 times already along with taken sorafenib for 36 months. No recurrence took place for 55 months over the past follow-up. Therefore, multidisciplinary treatment plan for peritoneal recurrence of HCC, including medical resection, may enhance prognosis.We report a case of splenic lymph node recurrence 7 years after a distal bile duct carcinoma. A 70s man underwent pylorus ring-preserving pancreaticoduodenectomy for distal bile duct carcinoma in 20XX. The pathological diagnosis ended up being T2N0M0, Stage Ⅱ(Japanese Classification of the Biliary Tract Cancers 5th version). Then, S-1 was administered as an adjuvant chemo- therapy 1month later and continued for three years. At 7 years postoperatively, the serum CEA amount was elevated(CEA 77.0 ng/ mL), and FDG-PET showed high-grade accumulation in the splenic hilum lymph node, that was diagnosed as lymph node recurrence. Because it ended up being  https://pparsignaling.com/yellowhorn-drought-induced-transcription-aspect-xswrky20-behaves-as-a-good-regulator-in-shortage-stress-by-means-of-ros-homeostasis-and-also-aba-signaling-pathway/  a solitary metastasis and had a lengthy recurrence-free duration, tumefaction resection was not performed, therefore the patient plumped for a nonsurgicaltreatment. No recurrence occurred to date. Recurrent resection is hardly ever carried out for splenic lymph node metastasis.An 80-year-old man had been regarded our medical center as a result of jaundice and fatigue. Abdominal computed tomography(CT) scan revealed an extrahepatic bile duct tumefaction, and biliary cytology detected adenocarcinoma; consequently, subtotal stomachpreserving pancreaticoduodenectomy had been done. Histological evaluation indicated that the tumor had been a well-differentiated adenocarcinoma without lymph node metastasis. Two years after the preliminary surgery, blood examination detected an increased serum CA19-9 amount and submucosal tumefaction which can be 2.5 cm diameter with an ulcer at the gastrojejunostomy anastomosis. Tumefaction biopsy was done, and histological analysis revealed a recurrent cholangiocarcinoma. The tumefaction straight invaded the transverse colon mesentery; therefore, distal gastrectomy and correct hemicolectomy were carried out. The patient survived 12 months postoperatively without recurrence. Gastric metastasis from cholangiocarcinoma rarely takes place. Intraoperative exposure of bile liquid could have caused gastric metastasis in this case.Currently, chemotherapy against unresectable advanced gastric cancer tumors is progressing using the development brand-new medicines and as a result of link between a few clinical trials. Right here, we reported an instance of lasting success of gastric cancer tumors with numerous liver and lymph node metastases. A 68-year-old guy was diagnosed with gastric cancer and Virchow lymph node, para-aortic lymph node, and several liver metastases at another hospital. He was referred to our medical center from Yamashita Naika Syokakika. We administrated 4 classes of S-1 plus CDDP. The primary tumefaction and all sorts of metastatic lesions had been significantly decreased. Subsequently, total gastrectomy, limited liver resection, and left throat and para-aortic lymph node resection(conversion surgery)were done. The cancer tumors mobile had been remnant in the primary tumor and para-gastric lymph node. No disease cells were detected in another lesion(R0 resection). Postoperatively, only S-1 had been administered. Nonetheless, 28 months after undergoing gastrectomy, liver metastasis took place. Therefore, S-1 plus oxaliplatin, paclitaxel plus ramucirumab, and CPT-11 plus CDDP had been administered. Liver metastases once more increased and diminished, respectively. Nonetheless, 46 months after gastrectomy, liver metastasis recurred and nivolumab was administered. Later, liver metastases vanished. At 55 months after gastrectomy, rectal resection was carried out against rectal cancer tumors and partial liver resection against liver metastases. Cancer cells were not detected within the resected specimens.A girl in her 40s was hospitalizedfor jaundice. Six years before, she hadbeen diagnosedwith synchronous esophageal andgastric cancers andhadund ergone subtotal esophagectomy andtotal gastrectomy, accompaniedby reconstruction using the pedicled jejunum. Multimodal imaging revealed a tumor in the pancreatic head, probably pancreatic cancer tumors, which induced extreme stenosis of the intrapancreatic bile duct. Scraping cytology findings regarding the lesion through the percutaneous transhepatic cholangial drainage(PTCD)route strengthenedthe suspicion. When you look at the picture, although no obvious invasion for the significant vessels or obvious remote metastases were recognized, an abnormal shadow was discovered continuously coating the main cyst andpara -aortic area, that was a contraindication for curative resection. Therefore, we performed neoadjuvant chemotherapy with gemcitabine plus S-1. After 3 classes, the lesion size paid down notably, and pancreatoduodenectomy was carried out. The pathological analysis ended up being pancreatic cancer(ph, ypT3, ypN1a, ypM0, ypStage ⅡB). Aside from pancreatic fistulas(Clavien-Dindo Ⅲa), the postoperative clinical course had been uneventful, andshe ended up being dischargedon postoperative day 27. Up to now, the patient is live without recurrence and is undergoing adjuvant chemotherapy with S-1.A 50-year-old girl ended up being referred to our hospital due to breast cancer with several liver metastasis diagnosed by CT scan. Laboratory findings showed liver dysfunction(T-Bil 7.6mg/dL)with marked elevation of tumor markers(CEA 727.9 ng/mL). Breast tumor biopsy showed an invasive ductal carcinoma(scirrhous kind), ER(+), PgR(-), and HER2(3+). Mix treatment with docetaxel, carboplatin and, trastuzumab had been administered following the end of just one span of regular paclitaxel plus bevacizumab regimen. The patient maintained a great problem without liver dysfunction 8 months after the first check out. Follow-up CT scan showed limited reaction of breast and hepatic tumors. Our case implies that mindful chemotherapy can improve the prognosis of cancer of the breast with liver metastasis whether or not an individual is in an icteric condition.A 69-year-old girl was accepted to the hospital because of stomach pain.